about
sameAs
Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibilityAnterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivinNuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferaseSuppression of cancer cell growth by promoting cyclin D1 degradationPhosphorylation-dependent regulation of SCF(Fbx4) dimerization and activity involves a novel component, 14-3-3ɛTherapeutic Implications for Overcoming Radiation Resistance in Cancer TherapyMechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signallingNovel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phasHsc70 regulates accumulation of cyclin D1 and cyclin D1-dependent protein kinaseTime- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2.Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk.Identification of a human cyclin D1-derived peptide that induces human cytotoxic CD4 T cellsInsulin Promotes the Proliferation of Human Umbilical Cord Matrix-Derived Mesenchymal Stem Cells by Activating the Akt-Cyclin D1 Axis.Biological and clinical significance of GSK-3beta in mantle cell lymphoma--an immunohistochemical study.Comparative proteomic analysis of differentially expressed proteins in primary retinoblastoma tumors.Pekinenin E Inhibits the Growth of Hepatocellular Carcinoma by Promoting Endoplasmic Reticulum Stress Mediated Cell Death.Lactate dehydrogenase A promotes the invasion and proliferation of pituitary adenoma.Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.7,3',4'-Trihydroxyisoflavone inhibits epidermal growth factor-induced proliferation and transformation of JB6 P+ mouse epidermal cells by suppressing cyclin-dependent kinases and phosphatidylinositol 3-kinase.Uncovering the role of genomic "dark matter" in human disease.Tailoring to RB: tumour suppressor status and therapeutic response.Inhibition of tumor growth and metastasis by non-small cell lung cancer cells transfected with cyclin D1-targeted siRNAMechanisms by which IGF-I may promote cancerInduction of apoptosis coupled to endoplasmic reticulum stress in human prostate cancer cells by n-butylidenephthalide.Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cellsCdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin/T-cell factor transcriptional activity.Ubiquitin-dependent proteolysis in G1/S phase control and its relationship with tumor susceptibilityDiscovery of multi-dimensional modules by integrative analysis of cancer genomic data.The history and future of targeting cyclin-dependent kinases in cancer therapy.Cell cyclins: triggering elements of cancer or not?Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231.Non-Coding RNAs: Functional Aspects and Diagnostic Utility in OncologyBisdemethoxycurcumin-induced S phase arrest through the inhibition of cyclin A and E and induction of apoptosis via endoplasmic reticulum stress and mitochondria-dependent pathways in human lung cancer NCI H460 cells.Cells lacking IKKα show nuclear cyclin D1 overexpression and a neoplastic phenotype: role of IKKα as a tumor suppressorCyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcomeCorrelation of cyclin D1 expression with aggressive DNA pattern in patients with tobacco-related intraoral squamous cell carcinoma.Redox regulation of cardiomyocyte cell cycling via an ERK1/2 and c-Myc-dependent activation of cyclin D2 transcriptionIn vivo and in vitro analysis of age-associated changes and somatic cellular senescence in renal epithelial cells.A novel topoisomerase inhibitor, daurinol, suppresses growth of HCT116 cells with low hematological toxicity compared to etoposide.Versatility of PRMT5-induced methylation in growth control and development.
P2860
Q21184029-1395A55D-F697-4984-96BC-046540113DF5Q21195209-78C2F44B-FA54-476B-B00B-76467A59D9EEQ24303548-85945B65-C3AF-49A5-85FB-93C76A531192Q24317660-FDEC154A-70BA-44C5-A0AD-92248D81DE83Q24337479-DC54C466-E2A5-44F1-988E-AC1239554B84Q26777016-D995D23A-0077-4C27-9ED0-0125C42B99CBQ28478858-75A30685-86C4-46E9-B6FC-F10C6368206FQ28567562-6F9A7103-1706-46BA-A724-216E3CA347A3Q28585533-1FA8A6E2-FAB3-4E96-95F9-4F009B44CE66Q33260499-15076876-B778-44E9-A208-6C22C2D52397Q33314644-D05BF661-CE53-490E-B45F-F3827BB2876EQ33496761-52270BA7-A801-4AD1-8D6B-C688E2D3D302Q33623964-106465D8-D4DE-4C8A-AABD-E20C245D42CCQ33719167-A3A1E01B-E018-4F22-9D93-60F9F54BBCEFQ33764488-9733C603-670E-483E-A22A-562528B4F381Q33849350-92B5904A-75DE-40B9-9240-888FBDED724AQ33875716-AB7D1DA2-DC1D-40B0-B22B-0242AA6BA236Q33922936-0C127466-CF27-4742-BE8F-CAE650EC39BFQ33967370-23471317-9376-4EB0-94CC-40C5F5C39446Q34031710-B7B3194D-107B-44D2-BC61-4A0C0C5D5877Q34040108-0AD5A561-5541-47CE-B1E8-0C027BD5E12AQ34167898-9D38348F-2814-4C91-922C-2FC4F330CF3BQ34180961-C5FA85B9-ADE7-4DC3-9E22-4FFEEDCE540FQ34217464-72C5A303-C45C-423E-83A9-3E4A8910C885Q34246676-4FD04F02-3643-4D2B-93C0-F010242DB979Q34328821-059028CD-7AA7-4B55-AD86-A3FDB95B8694Q34346963-F4DF112B-0AA4-4074-9712-318DB8C879FDQ34373598-C95977DB-B298-48B8-8D89-678942A4AC60Q34460347-0D4FBAA0-E2EB-4823-9CE8-2430DDB6CF57Q34467866-CFEEC089-43E0-41EA-81E0-61B356238E84Q34545864-A552B1DE-EECC-4AF7-9B07-21AE41287845Q34605730-127AF5D8-3E0D-433C-92D1-73F75809272BQ34673080-185C8C1A-1615-4745-8881-EB4FB85C04C3Q34768844-AA379430-EF1E-4DC6-89CF-8C52FF86354AQ34775678-B2B7FA44-CAE4-4A5D-9C22-C34870B0C882Q35010500-5C5A48C6-2D9A-4048-B036-03A986E3F84DQ35033118-AE585453-3356-4A98-8E4E-9B3FA60A79DCQ35088464-44108977-2FA9-4CF3-A80D-927E2E756C5FQ35571888-73B310E9-99BB-4D8D-B1E4-0D4D90060F6BQ35577094-D8F12312-C9E2-4B37-826D-5C5277C91AA8
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cycling to cancer with cyclin D1
@ast
Cycling to cancer with cyclin D1
@en
Cycling to cancer with cyclin D1
@nl
type
label
Cycling to cancer with cyclin D1
@ast
Cycling to cancer with cyclin D1
@en
Cycling to cancer with cyclin D1
@nl
prefLabel
Cycling to cancer with cyclin D1
@ast
Cycling to cancer with cyclin D1
@en
Cycling to cancer with cyclin D1
@nl
P3181
P356
P1476
Cycling to cancer with cyclin D1
@en
P2093
J Alan Diehl
P304
P3181
P356
10.4161/CBT.72
P407
P577
2002-01-01T00:00:00Z